$RIV $RIV.V $CNPOF Where Beauty and Wellness are Being Significantly Disrupted by Cannabis

$TGODF $TGOD Receives Health Canada Licence to Sell Cannabis Oils

TORONTO, April 22, 2019  – The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) (US:TGODF) is pleased to announce it has received its oil sales licence from Health Canada pursuant to the Cannabis Act for its Hamilton, Ontario facility.

The Company received its oils production licence in April of 2018 and subsequently installed a state-of-the-art supercritical CO2 extraction system, capable of processing ultra-pure, environmentally friendly, organic cannabis oils. The process is free of toxic solvents and does not require any winterization protocol. The result of this specialized extraction process is a precisely concentrated, aromatic golden-brown oil that is as close to the original plant composition as can be achieved. TGOD’s premium cannabis products, including its cannabis oils, are certified organic by ProCert and its innovative growing process is certified organic by both ProCert and Ecocert, producing a clean, high-quality end product.

TGOD’s oil extraction facility was built to GMP (Good Manufacturing Practices) specifications, and work is currently underway for European Union GMP (“EU-GMP”) certification, which will allow the Company to expand distribution of its certified organic cannabis oils beyond Canada to global markets.

“We are pleased to offer TGOD’s medical patients access to new premium certified organic cannabis oils,” said Brian Athaide, TGOD CEO. “In addition, this step will assist TGOD in transforming our premium quality organic raw material into a variety of higher-margin cannabis products which is core to our business plan, providing us with the opportunity to bring to market innovative and novel products, including beverages and edibles, once regulations permit. Cannabis 2.0 is rapidly approaching, and we will be ready,” continued Athaide.

TGOD’s oils will be as close to the original plant as possible, including terpene profiles to realize entourage effects. The process is easily customizable to create full-spectrum strain-specific oils, as well as oils of varying cannabinoid and terpene concentrations.

“Oil is predominantly a medical product, and patients want clean, organic efficacy with safe and easy delivery,” said Dr. Rav Kumar, Chief Science Officer of TGOD. “Through our certified organic product and process we know we are providing patients the best possible experience.”

In March, the first group of patients, the Growers’ Circle, received access to purchase TGOD’s first certified organic cannabis strain through the website and the feedback has been extremely positive from all across the country. TGOD’s Unite Organic Cannabis Oil, derived from a high-potency THC-dominant strain, will begin shipping later this month.

To sign up for the Unite Organic waitlist, please visit TGOD’s patient center at TGOD.ca or call 905-304-4201.

On Behalf of the Board of Directors,
The Green Organic Dutchman Holdings Ltd.

About The Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) is a publicly traded, premium global organic cannabis company, with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned capacity of 219,000 kgs and is building 1,643,600 sq. ft. of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark.

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol “TGOD” and “TGOD.WT”, respectively.

For more information on The Green Organic Dutchman Holdings Ltd., please visit www.tgod.ca.

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward looking statements in this release includes, but is not limited to, statements about future research, development and innovation by the Company, statements about EU-GMP certification, statements about production timing, efficiencies, capacities and ramp-up, statements about future production, revenue, export capabilities and cashflows, statements about the offering or efficacy of any particular products by the Company in any jurisdiction and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.

$GNPX Is ‘One to Watch’

$GNPX Positive Preclinical Data on Non-Small Cell Lung Cancer Treatment

• Genprex’s collaborators at MD Anderson reported positive preclinical data for the combination of the TUSC2 gene with an anti-PD1 antibody for the treatment of non-small cell lung cancer
• The TUSC2 gene, a tumor suppressor gene, is the active agent in Genprex’s Oncoprex immunogene therapy, the company’s lead drug candidate for the treatment of lung cancer
• In combination with pembrolizumab, the TUSC2 gene significantly slowed tumor growth in mice with human immune cells
• Lung cancer ranks among the malignancies that are expected to increase the most in the coming years, especially among women; immunotherapy solutions may provide an effective option for the treatment of such cancers

Genprex Inc. (NASDAQ: GNPX), a clinical stage gene therapy company, reported in a press release that its University of Texas MD Anderson Cancer Center collaborators have recorded positive preclinical data in a lung cancer treatment study (http://nnw.fm/8E4bC). The results of the study, which analyzed the combination of the TUSC2 gene and anti-PD1 antibody pembrolizumab, were presented in a poster at the 2019 American Association of Cancer Research Meeting. TUCS2 is a tumor suppressor gene and the active agent in Genprex’s Oncoprex immunogene therapy.

The poster data showed that TUCS2 in combination with checkpoint blockade was more effective than checkpoint blockade alone in increasing the survival of mice with…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$TGODF $TGOD Fast-tracks Canadian Hemp Strategy through Extraction Services Contract

$GGBXF Announces Nevada Launch of its First Proprietary Cannabis Brand

$TCAN Completes Sub-Lease Of 10k Sq. Ft. Facility in CA

Vancouver, British Columbia–(April 18, 2019) – TransCanna Holdings Inc. (CSE: TCAN) (XETR: TH8) (“TransCanna” or the “Company”) announces that it has executed a sub-lease agreement for 10,000 square feet of a multipurpose facility located in Adelanto, CA. The terms of the sub-lease agreement is four years at US$2.00 per square foot per month. The facility is of superior quality and has existing armed security personnel at all times at the complex.

“As we’ve represented since the commencement of TransCanna, it’s crucial to have a main facility, which we now have with the acquisition of the 196,000 square foot vertically integrated facility in Modesto, and up to five satellite facilities located strategically throughout the state,” stated Jim Pakulis, CEO of TransCanna. “This is in preparation for TransCanna to provide our clients with up to fifteen reliable, consistent branded products in a timely manner. In order to do that to scale, we needed to have a significant size nursery, grow, manufacturing, bottling, baking, extracting, and transportation and distribution facility and satellite offices, which we now have. Separately but related, we negotiated lease terms that are approximately thirty percent below market rates, with the added benefit of a completely fenced complex and armed security guards present at all times.”

The Company has terminated a previously signed LOI for 15,000 square feet for $2.25 per square foot per month. The landlord of that lease has yet to complete the facility as originally expected.

The Company has extended its marketing contract with Rok Marketing (a/k/a Rok Management) on existing terms with the exception of increasing the number of shares issuable per month to 30,000. All securities issuable will be subject to a four month hold period pursuant to the policies of the CSE.

For further information, please visit the Company’s website at www.transcanna.com.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.

Media Contact
TransCanna@talkshopmedia.com
604-738-2220

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (604) 609-6199

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to: the anticipated timing of the closing of the facility acquisition and the use of proceeds from the financing. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

$NUGS Applauds Portfolio Company Asher House Wellness on Ellen Show Appearance

LOS ANGELES, April 17, 2019 — via NetworkWire — Los Angeles-based Cannabis Strategic Ventures, Inc. (OTC: NUGS) congratulates portfolio company The Asher House Wellness on its continuing drive to expand the Asher House mission. Most notably, company co-founders Lee Asher and Luke Barton appeared on ABC’s “The Ellen DeGeneres Show” this week to discuss their deep commitment to move dogs out of shelters and into loving homes on a national and international level. The Asher House team, which depends on sales of hemp-based “Asher House Wellness Thrive Oil” to fund outreach efforts, is also introducing new phytocannabinoid (CBD) products as part of the Asher House Wellness product offerings.

“We are so grateful for the continued growth of The Asher House. The more people know about the Asher House, the more dogs we will be able to rescue,” said Lee Asher. “In addition, the more the community knows about and supports the Asher House Wellness and their industry-leading products that help dogs live well and thrive, the longer we will be able to continue our mission.”

In 2017, the Asher House founders embarked on a cross-country mission to get dogs out of shelters and into loving homes. Since then the brand’s co-founders have been traveling from state to state and Canada in an RV with six rescue dogs, working closely with local animal shelters or humane societies to set up dog adoption events. To date, the Asher House has successfully enabled the adoption of over 200 dogs.

“Cannabis Strategic Ventures is proud to support The Asher House mission and their commitment to help get dogs adopted throughout the United States and Canada,” said Simon Yu, CEO, Cannabis Strategic Ventures. “It is rare to find a company that is walking the talk and creating industry leading products while also dedicating personal resources to help their mission.”

The Ellen Show episode featuring The Asher House team and their adoption efforts was first aired April 15, 2019, and can be seen on EllenTube in a clip titled, “Ellen Meets Inspiring Dog Adoption Duo.”  The Ellen Show currently has 31 million followers on YouTube to complement its national reach.

The Asher House Wellness team plans to launch several new dog products in 2019 that includes “Lillie’s Love Biscuits.”

“We are excited for future Asher House Wellness and their commitment to creating products that encourage the happiness, health, and well-being of dogs and their humans worldwide,” added Yu.

Cannabis Strategic Ventures acquired a controlling interest in The Asher House Wellness, a brand producing pet goods created with full-spectrum, whole-plant hemp, free of THC and pesticides, in 2018 (http://nnw.fm/3hKpk).

About Cannabis Strategic Ventures
Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS.

FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance.

Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance.

Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.

Contact:
Arlene Guzman
Phone:+1-310-359-6860
Email: IR@CannabisStrategic.com
Website: http://www.CannabisStrategic.com

Corporate Communications:
NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

$MLNLF ~100% Increase to 4.2 Million Tonnes Lithium M&I at Pastos Grandes

Vancouver, British Columbia–(April 17, 2019) – Millennial Lithium Corp. (TSXV: ML) (the “Company”), is pleased to report an updated lithium (“Li”) and potassium (“K”) resource statement for its Pastos Grandes brine project in Salta province of Argentina. The NI 43-101 resource statement, detailed in Table 1 below, includes 4,120,000 tonnes of lithium carbonate (“Li₂CO₃“) equivalent (LCE) and 15,342,000 tonnes of potash (“KCl”) equivalent in the Measured and Indicated Resource categories, with an additional 798,000 tonnes ofLCEand 2,973,000 tonnes KCl in the Inferred Resource category. Compared to resource estimates completed by Montgomery & Associates in its previous report titled Measured, Indicated and Inferred Lithium and Potassium Resource Estimate Pastos Grandes Project Salta Province, Argentina and dated December 22, 2017, the updated resources represent an almost 100% increase in the Measured and Indicated LCE tonnage (2017 value of 2,131,000 tonnes LCE).

Farhad Abasov, President and CEO of Millennial Lithium, commented on the updated resources for the Pastos Grandes Project: “We are very excited to see from calculations by our hydrogeological consultants Montgomery & Associates, an approximately 100% increase in the Measured and Indicated lithium resources estimate over the 2017 Measured and Indicated Li resources. This sizable increase in our resource positions Millennial as one of the most prospective lithium brine projects in the world with the potential for a significant lithium operation. The Company now has significant Measured and Indicated lithium resources which, on the completion of ongoing studies, have the potential to be converted to Probable and Possible reserves in support of our Feasibility Study on the Company’s planned lithium carbonate processing operation. Our development work continues with the Feasibility Study and the construction of the pilot processing plant, both slated for completion in Q2.”

Table 1. Updated Pastos Grandes Brine Resource Statement

*Cut-off Grade = 300mg/L Lithium
*Tonnages are rounded to the nearest thousand
The reader is cautioned that mineral resources are not mineral reserves and do not have demonstrated economic viability

The resource estimate was prepared in accordance with the guidelines of National Instrument 43-101 and uses best practice methods specific to brine resources, including a reliance on core drilling and sampling methods that yield depth-specific chemistry and effective (drainable) porosity measurements. The resource estimation was completed by independent qualified person Mr. Michael Rosko, M.Sc., C.P.G. of the international hydrogeology firm E.L. Montgomery and Associates (M&A).

The resource is defined over a 45 square kilometer footprint using results from rotary and core drilling and depth-specific packer sampling. In addition, the brine was also sampled during long-term (21 days) and short-term pumping (72 hours) tests. The new measured, indicated, and inferred resource was derived from geological and grade/width block models derived from 15,135 metres of core and rotary drilling. The average spacing between core holes is less than 1 km. Geophysical surveys were used to assist with location and anticipated depths for the core holes, but also to identify potential fresh water and to extend the inferred resource. Over most of the basin, the brine resource occurs to within 1 metre of surface and its thickness is defined by the extent of drilling. The maximum depth drilled was 641 metres near the center of the mining concessions, bottoming in a sandy aquifer. The deepest brine sample was obtained at a depth of 641 metres and had a Li concentration of 495 milligrams per litre.

The chemistry of the Pastos Grandes brine is judged to be very favourable. Brine density and the ratios of magnesium and sulfate to lithium are:

• Density of the brine ranges between 1.20 and 1.22 g/cm³
• Average Magnesium/Lithium ratio: 6.2
• Average Sulphate/Lithium ratio: 19.3

Based on the geologic model, approximately 76% of the brine volume in this resource is hosted by predominantly silty and sandy units and 21% by mixed halite. The balance is hosted in gravel or clay dominated units.

The total contained lithium and potassium values are based on measurements of effective (drainable) porosity distributed throughout the aquifer volume that defines this resource. This method of porosity determination is designed to estimate the portion of the total porosity that can theoretically be drained by pumping; however, these in situ estimates may differ from total extractable quantities. The porosity of the resource volume varies with geology but to date effective porosity has been predictable within distinct hydrostratigraphic units; the average for the entire saturated aquifer considered in the resource is approximately 11%.

Portions of the resource located in the clastic sediments at the margins of the salar have been demonstrated to have fresh and brackish water overlying brine. In these areas, fresh water inflow from the surface mixes with salt water in the basin; the resulting lower density fresh water and brackish fluid float on top of the more dense brine before entering the salar margins.

Resource Estimation Methodology

A total of 15,135 metres of drilling from 33 holes was evaluated for this resource estimate calculation. Other core holes and wells were drilled but were shallower. A total of 144 drainable porosity results and 311 depth-specific brine sample analyses were used in the computations, not including QA/QC samples or composite samples obtained during pumping tests. The average spacing of vertical samples for brine chemistry analysis was variable with an average of 25 metres for depth-specific brine samples. Of the 33 holes used for the resource analysis, all were terminated due to drill limitations (hydrogeologic basement was not encountered). The total thickness of the basin and the total thickness of saturated sediments are unknown. Based on drilling, additional brine-bearing aquifer material is likely to exist below 600 metres in the concession area.

The consultants chose to estimate the updated resource using Leapfrog Edge, a well-known 3-dimensional block modeling software tool. Hydrostratigraphic units have variable thickness and were determined by the consultants based on observed lithology and anticipated similar hydraulic properties.

The values for drainable porosity and grade (lithium and potassium values) for each hydrostratigraphic unit were derived from direct measured values from the well. The unit thicknesses combined with the areas yield a volume. The volumes combined with the drainable porosity values, representing the amount of fluid available from the formation yield the volume of brine. Applying the grade, represented as lithium carbonate and potassium chloride equivalents reported as weights by volume of brine then provides the estimated resource for each block, which are then summed.

The primary analytical laboratories for the data used in this resource are NORLAB in Jujuy, Argentina and SGS Laboratory in Buenos Aires, Argentina. Both laboratories are accredited to ISO 9001:2008 and ISO14001:2004 for their geochemical and environmental labs for the preparation and analysis of numerous sample types, including brines.

The porosity determinations were made by Core Laboratories of Houston, Texas and Geosystems Analysis (GSA) of Tucson, Arizona. Core Laboratories is a leading provider of proprietary and patented reservoir description, production enhancement and reservoir management services. Core Laboratories has demonstrated that its Quality Management System is in compliance with certification to ISO 9000:2008. The scope of this registration is: providing state of the art petrophysical and geological analysis and interpretation of core samples from rock. GSA has gained abundant experience since 1994 in methods used by Core Laboratories and has provided services to various other lithium projects located in Argentina and globally.

Qualified Person

The resource evaluation work was completed by Mr. Michael Rosko, M.Sc., C.P.G. of Montgomery and Associates Consultores Limitada (“M&A”). Mr. Rosko is a Registered Geologist (C.P.G.) in Arizona, California, and Texas, a Registered Member of the Society for Mining, Metallurgy and Exploration, and is a qualified person (QP) as that term is defined by NI 43-101. Mr. Rosko and hydrogeologists from M&A have been on site multiple times during the various phases of drilling and sampling operations. Mr. Rosko has extensive experience in salar environments and has been a QP on many lithium brine projects. Mr. Rosko and M&A are completely independent of Millennial Lithium. Mr. Rosko has reviewed and approved the content of this news release.

Program design and exploration support was provided by Mr. Iain Scarr, (B.Sc. – Geology, MBA, CPG) of Millennial Lithium. Mr. Scarr is a Certified Professional Geologist (CPG) with the American Association of Professional Geologists (AIPG) and a QP as defined in NI 43-101. Mr. Scarr has spent significant time on site at Pastos Grandes during all drilling and sampling operations and has extensive experience with lithium projects at other lithium bearing salars.

A Technical Report prepared under the guidelines of NI 43-101 standards describing the resource estimation will be filed on SEDAR within 45 days of this release.

To find out more about Millennial Lithium Corp. please contact Investor Relations at (604) 662-8184 or email info@millenniallithium.com.

MILLENNIAL LITHIUM CORP.

“Farhad Abasov”

President and CEO, Director

MILLENNIAL LITHIUM CORP.
1177 West Hastings Street
Suite. 2000
Vancouver, BC Canada V6E 2K3
Tel: (604) 662-8184
Fax: (604) 602-1606
E-Mail: info@millenniallithium.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This document may contain “forward-looking information” within the meaning of Canadian securities legislation (hereinafter referred to as “forward-looking statements”). All statements, other than statements of historical fact, included herein including, without limitation statements relating to the Preliminary Economic Assessment, estimated capital and operating costs, productions rates, cash flows, rates of return, mine life or mineral resources, securing of debt for future project construction, purchase of future mine production, the timing for completion of an Feasibility Study and other matters related to the exploration and development of the Project, are forward-looking statements. These forward-looking statements are made as of the date of this document and the Company does not intend, and does not assume any obligation, to update these forward-looking statements. Forward-looking statements relate to future events or future performance and reflect management’s expectations or beliefs regarding future events. By their very nature forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include unsuccessful exploration results, changes in metals prices, changes in the availability of funding for mineral exploration, unanticipated changes in key management personnel and general economic conditions, title disputes as well as those factors detailed from time to time in the Company’s interim and annual financial statements and management’s discussion and analysis of those statements, all of which are filed and available for review on SEDAR at www.sedar.com. In certain cases, forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative of these terms or comparable terminology. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward looking statements.

$TGOD $TGODF Meeting Consumer Preferences with Organic Cannabis Product Line

• The United Organic strain is now shipping to more than 200 medical patients enrolled as Growers’ Circle members in Canada
• TGOD’s second organic certification for its Hamilton facility was recently received from Pro-Cert Organic Systems Ltd.
• Company’s multi-year extraction services agreement with Valens GroWorks Corp. is expected to accelerate the market entry of CBD-infused products

Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) is focused on becoming the global leader in delivering premium organic cannabis solutions to enhance the lives of people around the world. If 2018’s accomplishments are any indication of what’s to come, then TGOD is well on its way to realizing its strategic vision, as TGOD Director and CEO Brian Athaide stated in a news release (http://nnw.fm/C5gje).

“2018 has been a pivotal year for the company. The accomplishments our team has made have been nothing shy of incredible,” Athaide noted in the release…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://nnw.fm/TGODF

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$NUGS Model of Industry Best Practices for Innovation, Brand Development and Product Quality

• Cannabis Strategic Ventures supports entrepreneurial growth in the emerging legal cannabis and ancillary spaces
• The company boasts a portfolio of unique subsidiaries driving growth and opportunities for vertical integration
• The company is developing its NUGS Farm, and developing other hard asset projects is a priority for Cannabis Strategic Ventures

Cannabis Strategic Ventures Inc. (OTC: NUGS) incubates, develops and partners with category leaders within the cannabis space. Through a selective portfolio of companies, NUGS works to support entrepreneurial growth within the fast-emerging legal cannabis sector. Headquartered in Los Angeles, the company offers outsourced personnel solutions that are custom-made for its diverse clientele.

Cannabis Strategic focuses on leading the way in defining industry best practices for innovation, brand development and product quality. Additionally, the company is committed to implementing a…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://nnw.fm/NUGS

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$LXRP Announces Further Details on Oak Hill Financial Inc. Engagement

Kelowna, British Columbia / April 16, 2019 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, advises that in connection with yesterday’s announcement regarding the engagement by Lexaria of Oak Hill Financial Inc. (“Oak Hill”), the agreement with Oak Hill has a one month term that is automatically renewed, subject to termination by either party, upon five business days notice. The monthly compensation payable to Oak Hill is $8,500.

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH(TM) delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),nicotine and other molecules.

www.lexariabioscience.com

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.

Alex Blanchard, Communications Manager

(250)765-6424 Ext 202

Or

NetworkNewsWire (NNW)

www.NetworkNewsWire.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements; or that results from any studies will be favorable or in any way support future business activities of any kind. Scientific R&D is often unpredictable and unanticipated results could emerge from any study and have a material impact. There is no assurance that any planned corporate activity, scientific study, R&D, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). TurboCBDTM, DehydraTECHTM technology and ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

$RIV $RIV.V $CNPOF Invests in High Beauty

$YGYI Posts Q4, Full Year 2018 Financial Results

$TCAN Completes Acquisition 196,000 Sq. Ft. Vertically-Integrated Cannabis Facility

Vancouver, British Columbia–(April 16, 2019) – TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) announces that it completed the purchase of a 196,000 square foot vertically integrated cannabis facility.

“A tremendous effort by the TransCanna team on closing arguably the largest vertically integrated cannabis focused facility in California,” stated Jim Pakulis, CEO of TransCanna. “Simultaneous to putting our efforts into purchasing the facility, we’ve been searching extensively for the key individuals who will be overseeing the day to day operations. We’ve made great strides over the past several weeks and should be able to start making announcements by the end of the month.”

The total purchase price for the Property was US$15 million. The Company’s CEO paid the seller a US$250,000 non-refundable deposit to secure the property, which has since been reimbursed by the Company, and the Company will pay an US$8 million down payment from the proceeds of the Company’s over-subscribed brokered private placement once closed (see news releases dated February 20, 2019 and March 14, 2019). In consideration of the issuance of 500,000 common shares of the Company, the seller of the building agreed to a carry back note of US$6.750 million at 7% p.a. interest only for up to thirteen months, with an initial maturity date of October 15, 2019, subject to a six-month extension. See March 20^th press release for additional terms.

The Company has also issued to the seller 1,200,000 share purchase warrants exercisable to acquire a common share of the Company at an exercise price of $2.60 per share until April 15, 2024, vesting in equal quarterly portions over a 12-month period commencing on February 21, 2019, notwithstanding the warrants were issued today.

Additionally, a success fee of up to 2,000,000 common shares was paid to Haywood Securities Inc. in consideration of financial advisory services being provided to the Company in connection with the facility acquisition.

All of the securities issuable to the seller or Haywood Securities Inc. in connection with the facility acquisition are subject to a four month hold period ending on August 16, 2019 as well as applicable restrictions under U.S. securities laws.

For further information, please visit the Company’s website at www.transcanna.com.

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

For further information, please visit the Company’s website at www.transcanna.com or email the Company at info@transcanna.com.

Media Contact
TransCanna@talkshopmedia.com
604-738-2220

On behalf of the Board of Directors

James Pakulis
Chief Executive Officer

Telephone: (604) 609-6199

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to: the anticipated timing of the closing of the facility acquisition and the use of proceeds from the financing. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

$NUGS Cannabis Inhalers Could Be the Next Asthma and Cancer Pain Med

$LXRP Engages Oak Hill Financial Inc. to Provide Investor Relations Services

Kelowna, BC / April 15, 2019 – Lexaria Bioscience Corp. (CNSX: LXX) (OTCQB: LXRP) (“Lexaria” or the “Company”) announces it has retained Oak Hill Financial Inc. (“Oak Hill”) to provide investor relations services to the Company in compliance with regulatory guidelines.

Oak Hill is a Toronto-based firm that develops strategic platforms for its clients that are utilized to gain exposure and recognition in the capital markets. Oak Hill provides asset management, capital market and investor relations services. Its team has marketed corporate issuers ranging in market cap from $10M to $1B in a variety of different sectors to the Canadian retail brokerage channel, family offices and institutional networks. Oak Hill’s team has experience across equity capital markets, equity research, portfolio management, institutional equity sales, and traditional investor relations – resulting in tailored and highly collaborative solutions.

Oak Hill will work closely with Lexaria to develop and deploy a comprehensive capital markets strategy and campaign. Activities will include providing an investor relations program catering to retail investors, marketing services and an ongoing client services program.

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH(TM) delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),nicotine and other molecules.

www.lexariabioscience.com

For regular updates, connect with Lexaria on Twitter https://twitter.com/lexariacorp

and on Facebook https://www.facebook.com/lexariabioscience/

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.

Alex Blanchard, Communications Manager

(250)765-6424 Ext 202

Or

NetworkNewsWire (NNW)

www.NetworkNewsWire.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements; or that results from any studies will be favorable or in any way support future business activities of any kind. Scientific R&D is often unpredictable and unanticipated results could emerge from any study and have a material impact. There is no assurance that any planned corporate activity, scientific study, R&D, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). TurboCBDTM, DehydraTECHTM technology and ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

$GNPX at Forefront to Advance Innovative Developments in Fight Against Lung Cancers

$GGBXF Files to Accelerate Expiration of Aphria Bid

COLUMBUS, OH, April 15, 2019

Media Contact: Ian Robertson, Executive Vice President, Communication Strategy, Kingsdale Advisors, Direct: 416-867-2333, Cell: 647-621-2646, Email: irobertson@kingsdaleadvisors.com; Investor Contact: Peter Horvath, CEO, Green Growth Brands Inc., Phone: 614-508-4222Copyright CNW Group 2019

$YGYI to Host Conference Call Reviewing 2018 Financial Results

$NETE Revenues Grow in 2018, Total Processing Volume Also Goes Up

• Sustainable growth in revenue mainly stemmed from the North American transaction solutions segment
• The total processing volume also grew to reach $3.3 billion, most of which was covered by North America
• Net Element subsidiaries like Aptito have been contributing to the U.S. market growth with the provision of cost-efficient, tailored and innovative niche services

Net Element Inc. (NASDAQ: NETE) recently announced solid financial growth in 2018. The company’s revenue over the year went up to $65.8 million, marking an increase of 10 percent on an annual basis. Growth through the company’s North American transaction solutions segment was the primary driver for the strong results, as the company’s management announced in an earnings conference call on April 2, 2019 (http://nnw.fm/sF47f).

The North American transaction solutions segment experienced annual growth of 16 percent in 2018. The United States accounted for 90 percent of the overall revenue, while international revenue contributed…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://nnw.fm/NETE

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

$NUGS Mounting Cannabis Business Demand for Outsourced Employmcent Services

$GNPX NetworkNewsAudio Broadcast, Gene Therapy Treatment for Cancer

New York, New York–(April 12, 2019) – Genprex Inc. (NASDAQ: GNPX)announces the availability of a NetworkNewsAudio broadcast titled, “Potential Blockbuster Gene Therapy Programs to Watch in 2019.”

To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/j1WMs

To read the full editorial, visit: http://nnw.fm/YC9iq

Genprex already has over 30 issued patents for its platform technologies. The company’s promising pipeline currently includes a phase I/II clinical trial underway to evaluate intravenous Oncoprex immunogene therapy in combination with another cancer drug, Tarceva, and pre-clinical research of the combination of Oncoprex immunogene therapy with immunotherapies.

Gene therapy programs may be on the cusp of curing the incurable, and the companies that deliver these medical miracles are in an ideal position to reap a bonanza of recognition and rewards. Given the promise of Genprex’s pipeline of cancer killers with global blockbuster potential, the company certainly appears to be one to watch.

About Genprex Inc.

Genprex Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. Visit the company’s web site at www.genprex.com or follow Genprex on Twitter at twitter.com/genprex, Facebook at facebook.com/genprexinc, and LinkedIn at linkedin.com/company/genprex.

About NetworkNewsAudio

NetworkNewsAudio (NNA) , a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) can assist your company by cutting through the overload of information in today’s market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.

For more information, visit: www.NetworkNewsAudio.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

$RIV.V $RIV.V $CNPOF Kentucky Advances Medical Marijuana Bill

$TGOD $TGODF California’s Cannabis Home Delivery Policy Faces Legal Challenge

$YGYI Subsidiary Expands through Acquisition of Land

$VVCIF $VIVIO to Post Q4, Full Year 2018 Results on April 30

$TGOD $TGODF U.S. Currently 2nd To China In Hemp Revenues

Palm Beach, FL – April 11, 2019 – In recent industry reports, China led all countries with nearly $1.2 billion USD in hemp sales in 2018, followed by the United States ($1.0 billion), Europe ($980 million) and South and Central America ($220 million). A recent report from an independent, technology-driven analytics company specializing in the cannabis industry stated that: “… the global hemp industry reached $3.7 billion USD in retail sales in 2018, with an annual growth rate of 15% driven by continued strength in Chinese textiles, European industrials, Canadian foods, and the U.S. hemp-derived CBD market.” This report is the first in-depth, quantitative and fact-based analysis of the global hemp industry since the United States’ 2018 Farm Bill and Canada’s Cannabis Act passed; two groundbreaking changes in North America that dramatically re-shaped the entire hemp industry.” By 2020, (the report data says) estimates the global market will reach $5.7 billion USD across all markets, representing a three-year compound annual growth rate (CAGR) of 17.5%.  The U.S. market, however, is positioned to grow under the 2018 Farm Bill, with an estimated $2.6 billion projected in sales by 2022, with $1.3 billion in sales estimated for hemp-derived CBD products by 2022. “As regulatory barriers diminish in the months and years ahead, businesses will continue to expand the ways in which hemp is utilized, especially across medicinal and industrial applications,” said (the author).  Active companies in the markets this week include The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC: TGODF), OrganiGram Holdings Inc. (TSX-V: OGI) (OTC: OGRMF), The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTC: SPRWF), MedMen Enterprises Inc. (CSE: MMEN) (OTC: MMNFF)

The report concluded: “The U.S. hemp industry is set to boom under the 2018 Farm Bill. American farmers have a new crop, and consumers are seeing an explosion of new and innovative products. Hemp: the ultimate triple bottom line crop for people, planet and profits,”   However a research report by a relied upon industry source, (The Brightfield Group) has previously projected that the: “Hemp CBD Market to Reach $22 Billion By 2022: Outpacing the Rest of the Cannabis Market Combined”, so while the projections may differ they agree that the future revenues will rise substantially in the next few years.

The Yield Growth Corp. (CSE:BOSS) (OTCPK:BOSQF) BREAKING NEWS:  Yield Growth Corp enters agreement with consultant Pontier Services to set up Urban Juve hemp beauty products for sales through China’s most popular messaging app, WeChat, and to launch a marketing campaign with a pop-up kiosk to rotate through luxury shopping malls and other major locations in Hong Kong for three months beginning in June 2019.    According to New Frontier Data, in 2017, Chinese hemp sales totaled $1.1 billion, approaching 1/3 of the $3.1 billion global market, with sales forecasted to grow to $1.5 billion (up 36%) by 2020.

The objectives of the pop up kiosk campaign will be to introduce Urban Juve’s brand story, Ayurveda philosophy and proprietary hemp root oil ingredient skin care products to the Chinese audience through the WeChat platform and to drive sampling and sales transactions through the kiosks.   The initial locations for the artificial intelligence enabled kiosk this summer will be 3 luxury shopping malls in Hong Kong, University of Science and Technology, Science Park and the Park Yoho residence clubhouse.

“The use of pop-up kiosks in shopping malls to promote online sales is an innovative way to reach the modern consumer,” says Penny Green, CEO of Yield Growth.  “We are excited to launch Urban June’s hemp products in the fast growing Chinese market this summer through WeChat.”  Urban Juve will be the first Canadian brand to launch PopSquare AI-enabled pop-up kiosks in China.  Through Pontier and PopSquare, Urban Juve will use big data, computer vision, sensor fusion and machine learning to deliver increased sales, deeper analytics and enhanced customer service.   Read this and more news for The Yield Growth Corp. at:  https://www.financialnewsmedia.com/news-boss

Other recent developments from yesterday and major influences in the cannabis/CBD industry include:

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTCQX: TGODF) recently announced that  is pleased that Hamilton City Council has voted to approve the Company’s settlement offer, to allow TGOD to operate its cannabis greenhouse in Ancaster, Ontario upon confirmation of the settlement by the Local Planning Appeal Tribunal at a meeting scheduled for April 25, 2019.

“This is tremendous news for our Company and for the city of Hamilton,” said Brian Athaide, CEO and Director of TGOD. “We are a global company that has its roots in Hamilton, and we are looking forward to expanding our production of high-quality, organic cannabis right here in our home town. This is important to TGOD’s ability to generate considerable near-term revenue while the Company continues to approach its global planned output of 219,000 kgs.”

The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) recently announced that it expects its previously announced oil products line to be introduced to adult-use consumers in select Canadian markets starting April, 2019.

Supreme Cannabis plans to initially ship oil products to select markets before expanding distribution of its cannabis oil line to additional provinces which is expected by the end of June, 2019. Each bottle will contain a proprietary blend of highly purified cannabis oils and terpenes derived from plants grown by 7ACRES.

OrganiGram Holdings Inc. (TSX-V: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis recently announced the recent appointment of strategy and operations consultant James Cavanagh as the Company’s Chief of Staff.

Mr. Cavanagh is an experienced professional who has worked with Canadian and global clients across a variety of industries to drive top and bottom-line growth as well as organizational and operational improvements. Previously with PwC, he has overseen the design and implementation plan of global manufacturing, corporate, and sales processes designed to strategically enhance performance and revenue. Mr. Cavanagh has also facilitated digital strategy development and implementation, introducing new technology platforms in order to improve critical business processes and help achieve cost reduction.

MedMen Enterprises Inc. (CSE: MMEN.CN) (OTCQX: MMNFF) recently announced that it has entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Canaccord Genuity Corp. pursuant to which the Company may, from time to time, sell Class B subordinate voting shares (the “Subordinate Voting Shares”) in the capital of the Company for aggregate gross proceeds of up to CDN$60,000,000 . The At-the-Market equity financing program (the “ATM program”) is designed to enable the Company to issue Subordinate Voting Shares from treasury at lower cost than traditional offerings, without discount and at prevailing trading prices. The Company intends to use the net proceeds from the sale of Subordinate Voting Shares under the ATM program principally for general and administrative expenses, working capital needs and other general corporate purposes.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM has been compensated forty nine hundred dollars for news coverage of the current press releases issued by The Yield Growth Corp. by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$RIV $RIV.V $CNPOF 2019 & Cannabis Companies In North America

Palm Beach, FL – April 11, 2019 – This year 2019 will be the year of maturation and expansion for the cannabis industry. Expectations are high and optimism abounds on all fronts. A recent article in Forbes echoed this optimism: “This new year bodes well for the cannabis industry. There’s excitement as we welcome new states into the cannabis fold and fervent hope that we’ll see movement toward making cannabis fully legal at the federal level. Momentum from several major developments in 2018, including the inclusion of industrial hemp in the new farm bill and Canada’s nationwide legalization, will certainly continue to fuel innovation, policy and entrepreneurship… there’s a lot of enthusiasm and a general expectation that the U.S. is moving toward an end of prohibition at the federal level.  It continued: “This is the year when we’re going to start to see a bifurcation between companies that are solid and those that aren’t. Up until now, cannabis has been a “rising tide lifts all the boats” kind of industry. But that won’t be true anymore. We’ll see people who are successfully executing their business plans get a major lift this year as consumer spending is expected to jump 40%. But we’ll also start to see inept companies fail. A lot of people blindly got into cannabis because it was hot or the next big thing and they’re going to pay a penalty for not knowing the industry. 2019 is going to be a reality check, which is a good thing for those companies that have solid, professional business plans in place, because we can expect retail investors to start to take a back seat to big money.   Active companies in the industry making moves to ready that include:  IONIC Brands Corp., (CSE: IONC), SLANG Worldwide Inc. (CSE: SLNG) (OTC: SLGWF), Plus Products Inc. (CSE: PLUS) (OTC: PLPRF),  Origin House (CSE: OH.CN) (OTC: ORHOF), Canopy Rivers Inc. (OTC: CNPOF) (TSX-V: RIV).

The article concluded: “Stocks were volatile for a few months at the end of 2018 because investors weren’t sure how the landscape would change after Canada’s switch to legal cannabis. But as institutional investors start coming in, they’ll take a hard look at everyone’s numbers and reward companies that are solidly performing and have the traditional hallmarks of a successful startup. That means capital is going to start migrating to the better players, which is going to further separate them from the pack. While there will be some fallout, in general, it’s a good thing for the market. An industry built on hype and expectation can’t survive. This is the year we’re going to see that performance and numbers matter.”

IONIC Brands Corp., (CSE: IONC) BREAKING NEWS:  IONIC Brands is pleased to announce that the Company’s product licensing partner has signed an exclusive distribution agreement with Continuum (“Continuum”) a California Division of  Origin House (“Origin House”) to distribute Ionic branded products.   Ionic branded products are now part of the Origin House distribution platform in California.  Origin House has the largest US footprint of branded and distribution assets in North America.

One of the Continuum strengths is its portfolio of over 30 cannabis brands, which it delivers to more than 500 dispensaries in California. Distribution is a critical part of the cannabis supply chain in California, where the legal cannabis market is expected to hit US$7.7 billion by 2020, according to Arcview Market Research/BDS Analytics.  The agreement also provides further potential access to 10 additional US states including Michigan, Massachusetts, Ohio, Pennsylvania, Illinois, Arizona, and Florida.

Effective immediately Continuum is the exclusive distributor of all Ionic Brands products in California.  Origin House’ Director of Key Supplier Relations, Jessica Lilga commented,“the California cannabis distribution market is very competitive. Continuum has the advantage to distribute the finest products from the best companies and we are excited to offer Ionic products to our customers.  The IONIC team meets our high standards of professionalism and experience, and we are very excited to help build this brand in California and potentially other states as our two companies expand our national footprint.”

IONIC BRANDS Chairman and CEO John Gorst commented that “IONIC BRANDS sought out the top distributor in California and given Origin House’ footprint, Ionic anticipates increased brand awareness, heighten demand for its products, and aggressive sales growth.  Our exclusive distribution agreement with Origin House distributor Continuum aligns with our strategy to build a multi-state consumer-focused cannabis concentrate national brand portfolio focusing on the premium and luxury segments.  We look forward to growing with Continuum as we build the market for our portfolio of premium cannabis branded products.”    Read this entire announcement  for IONC at:     https://www.financialnewsmedia.com/news-ionc/

Additional industry related developments from around the markets:

SLANG Worldwide Inc. (CNSX: SLNG) (SLGWF) –  At the request of the Investment Industry Regulatory Organization of Canada, Slang Worldwide Inc. has confirmed that the company’s management is unaware of any material change in the company’s operations that would account for the recent increase in market activity.

The company is presently pursuing a number of acquisition transactions, which transactions are at various stages of development. Any such transaction will be fully disclosed if and at such time as it becomes material information regarding the company.

Canopy Rivers Inc. (OTCPK: CNPOF) (TSX-V: RIV) –  James E. Wagner Cultivation Corp., a portfolio company of Canopy Rivers Inc., has received a cultivation license from Health Canada for its Kitchener-based commercial-scale production facility (JWC2). This second license launches the initial phase of JWC2, a 345,000-square-foot production and distribution complex, where James E. Wagner Cultivation is rolling out more than 130 individual production rooms utilizing its proprietary GrowthStorm dual-droplet cultivation platform and methodologies. With the newly licensed facility located just minutes from James E. Wagner Cultivation’s already licensed pilot facility, James E. Wagner Cultivation is well positioned for an efficient ramp-up and expects to commence cannabis production at JWC2 immediately.

“While optimizing production methodologies at their already licensed pilot facility, JWC has concurrently built out and implemented refinements and learnings for production at commercial scale,” commented Daniel Pearlstein, executive vice-president of strategy at Canopy Rivers. “We are pleased to see Health Canada reward JWC for the quality of their operations and their disciplined approach to expansion with the issuance of this second site licence.”

Plus Products Inc. (CSE: PLUS.CN) (OTCQB: PLPRF) has launched its newest product: mango CBD (cannabidiol) relief, which will contain 4.5 milligrams of cannabidiol and 0.5 mg of tetrahydrocannabinol in each gummy. The new product is already available at some of the more than 250 retailers in California who carry the Plus product line.

The company will retire its previous CBD relief product, “pineapple coconut CBD relief,” as part of a co-ordinated launch campaign with retailers. According to BDS Analytics, pineapple coconut CBD relief was the top selling CBD edible in the California market in Q4 2018 as measured by units and dollars sold.

Origin House (CSE: OH.CN) (OTCQX: ORHOF) – CannaRoyalty Corp d/b/a Origin House  a North American cannabis products and brands company recently provided an update on Sonoma County permit approvals received by the Company’s pending acquiree, California -based cannabis cultivator Cub City LLC (“Cub City”) and wholly-owned subsidiary, FloraCal Farms (“FloraCal”).

Cub City received a Minor Use Permit (“MUP”) from the County of Sonoma for cultivation, processing, non-volatile manufacturing, and distribution at its Santa Rosa facility. The MUP was approved by a unanimous vote of the Sonoma County Board of Zoning Adjustments (the “Board”), following a public hearing on March 28, 2019 . The appeal period for the Board’s decision ended on April 8, 2019 without any appeal being filed.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty six hundred dollars for news coverage of the current press release issued above by IONIC Brands Corp. by a non affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

$GNPX Featured in NetworkNewsWire Publication on Revolutionary Gene Therapies

New York, New York–(April 11, 2019) – Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company for private and public entities.

To view the full publication, titled “Potential Blockbuster Gene Therapy Programs to Watch in 2019,” visit: http://nnw.fm/YC9iq

Perhaps no other disease strikes as much dread and fear as cancer. Many successful treatments are available today that didn’t exist just a couple decades ago; however, cancer cells and how they grow remain unpredictable and, in some cases, mysterious. Even after seemingly effective conventional treatments, cancer cells can hide out in some patients and resurface. Genprex Inc. (NASDAQ: GNPX) is pioneering a new approach to treating cancer.

Genprex’s initial product candidate, Oncoprex, is an immunogene therapy for non-small cell lung cancer (NSCLC), one of the most common causes of cancer deaths in the world. About 85% of lung cancers are non-small cell lung cancer. Survival rates for late stage non-small cell lung cancer haven’t improved significantly in over a quarter century. Genprex is in hot pursuit of life-changing gene technologies for patients facing this dismal outlook.

About Genprex, Inc.

Genprex, Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. Visit the company’s web site at www.genprex.com or follow Genprex on Twitter at twitter.com/genprex, Facebook at facebook.com/genprexinc, and LinkedIn at linkedin.com/company/genprex.

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets, (3) enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge. For more information, please visit https://www.NetworkNewsWire.com.

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com